Title |
Phosphate induced crystal acute kidney injury – an under-recognized cause of acute kidney injury potentially leading to chronic kidney disease: case report and review of the literature
|
---|---|
Published in |
International Journal of Nephrology and Renovascular Disease, March 2013
|
DOI | 10.2147/ijnrd.s41428 |
Pubmed ID | |
Authors |
S Lochy, R Jacobs, PM Honoré, E De Waele, O Joannes-Boyau, J De Regt, V Van Gorp, HD Spapen |
Abstract |
Acute phosphate nephropathy or nephrocalcinosis is a tubulointerstitial nephropathy characterized by tubular calcium phosphate deposition - crystal nephropathy - and slowly progressive renal insufficiency during or following treatment with preparations containing sodium phosphate. We report a patient who developed nephrocalcinosis (crystal induced acute kidney injury) following the administration of a combination of oral and rectal sodium phosphate for treatment of postoperative constipation. A timely renal replacement therapy procedure may reverse the process of crystallization and the irreversible slope towards chronic dialysis. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 25% |
United Kingdom | 1 | 25% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 50% |
Practitioners (doctors, other healthcare professionals) | 2 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 22 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 6 | 27% |
Researcher | 4 | 18% |
Student > Doctoral Student | 3 | 14% |
Other | 1 | 5% |
Professor | 1 | 5% |
Other | 3 | 14% |
Unknown | 4 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 55% |
Nursing and Health Professions | 2 | 9% |
Agricultural and Biological Sciences | 2 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Materials Science | 1 | 5% |
Other | 0 | 0% |
Unknown | 4 | 18% |